Maxim Group Downgrades Assertio Therapeutics (ASRT) to Hold
Maxim Group analyst Naz Rahman downgraded Assertio Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
